Taken together, these findings confirm that HMGA2 may be a functional target of miR‐9, and activation of the miR‐9/HMGA signaling pathway may be a potential mechanism that may be exploited for the prevention and/or treatment of HCC. This evidence concerns the gene HMGA2 and hepatocellular carcinoma.